• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素治疗期间血流动力学不稳定时的肠内营养供应:一项基于证据的综述。

Provision of enteral nutrition during vasopressor therapy for hemodynamic instability: an evidence-based review.

机构信息

Auburn University, Harrison School of Pharmacy, Department of Pharmacy Practice, Auburn, AL 36849, USA.

出版信息

Nutr Clin Pract. 2012 Aug;27(4):521-6. doi: 10.1177/0884533612448480. Epub 2012 Jun 11.

DOI:10.1177/0884533612448480
PMID:22689719
Abstract

Critical illness is associated with many complications that affect both medical and nutrition aspects of patient outcomes. Early enteral feeding is the preferred method of nutrition for patients in the intensive care unit due to apparent benefits in this patient population. However, these patients are also at risk for complications related to enteral nutrition (EN), which may be potentiated with the addition of vasopressors often used in the setting of hemodynamic instability. The clinician is often confronted with the decision of when to proceed with EN in critically ill patients who require vasopressors for hemodynamic support. This article reviews the effects of vasopressors on gastrointestinal blood flow, discusses complications associated with vasopressor use during EN, and proposes important considerations to determine the safety of EN in hemodynamically unstable patients requiring vasopressor support.

摘要

危重病与许多并发症相关,这些并发症影响患者的医疗和营养状况。由于在这类患者人群中具有明显益处,早期肠内喂养是重症监护病房患者首选的营养供给方式。然而,这些患者也存在与肠内营养(EN)相关的并发症风险,而在血流动力学不稳定的情况下经常使用血管加压素可能会加剧这些风险。临床医生经常面临这样的决策:对于需要血管加压素来支持血流动力学的危重病患者,何时开始进行 EN。本文综述了血管加压素对胃肠道血流的影响,讨论了在 EN 期间使用血管加压素相关的并发症,并提出了一些重要的考虑因素,以确定需要血管加压素支持的血流动力学不稳定患者进行 EN 的安全性。

相似文献

1
Provision of enteral nutrition during vasopressor therapy for hemodynamic instability: an evidence-based review.血管加压素治疗期间血流动力学不稳定时的肠内营养供应:一项基于证据的综述。
Nutr Clin Pract. 2012 Aug;27(4):521-6. doi: 10.1177/0884533612448480. Epub 2012 Jun 11.
2
Early enteral nutrition in critically ill patients with hemodynamic instability: an evidence-based review and practical advice.血流动力学不稳定的危重症患者的早期肠内营养:循证综述与实用建议
Nutr Clin Pract. 2014 Feb;29(1):90-6. doi: 10.1177/0884533613516167.
3
Vasoactive substances and their effects on nutrition in the critically ill patient.血管活性物质及其对危重症患者营养的影响。
Nutr Clin Pract. 2012 Jun;27(3):335-9. doi: 10.1177/0884533612443989. Epub 2012 Apr 13.
4
Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy.肠内营养在接受静脉血管加压素治疗的危重症患者中的耐受性和安全性。
JPEN J Parenter Enteral Nutr. 2013 Sep;37(5):641-51. doi: 10.1177/0148607112470460. Epub 2012 Dec 27.
5
Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients.医学营养治疗方案的初步证据:危重症患者的肠内营养喂养
J Am Diet Assoc. 2006 Aug;106(8):1226-41. doi: 10.1016/j.jada.2006.05.320.
6
Enteral nutrition in the cardiothoracic intensive care unit: challenges and considerations.心胸外科重症监护病房中的肠内营养:挑战与考量
Nutr Clin Pract. 2008 Oct-Nov;23(5):510-20. doi: 10.1177/0884533608323422.
7
Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.危重病患者的胃肠道并发症和药物治疗,以及在重症成年患者进行肠内喂养期间的药物治疗。
Nutr Clin Pract. 2010 Feb;25(1):32-49. doi: 10.1177/0884533609357565.
8
Enteral nutrition in critically ill patients with severe hemodynamic failure after cardiopulmonary bypass.体外循环后严重血流动力学衰竭的危重症患者的肠内营养
Clin Nutr. 2005 Feb;24(1):124-32. doi: 10.1016/j.clnu.2004.08.005.
9
When can we start early enteral nutrition safely in patients with shock on vasopressors?对于使用血管升压药治疗的休克患者,我们何时能够安全地开始早期肠内营养?
Clin Nutr ESPEN. 2024 Jun;61:28-36. doi: 10.1016/j.clnesp.2024.03.007. Epub 2024 Mar 12.
10
Early enteral nutrition in critically ill patients.危重症患者的早期肠内营养
Dimens Crit Care Nurs. 2012 Sep-Oct;31(5):267-74. doi: 10.1097/DCC.0b013e3182619944.

引用本文的文献

1
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?血管活性药物与营养治疗:肠内营养起始的安全剂量?
Crit Care Res Pract. 2020 Feb 10;2020:1095693. doi: 10.1155/2020/1095693. eCollection 2020.
2
What do we know about optimal nutritional strategies in children with pediatric acute respiratory distress syndrome?我们对小儿急性呼吸窘迫综合征患儿的最佳营养策略了解多少?
Ann Transl Med. 2019 Oct;7(19):510. doi: 10.21037/atm.2019.08.25.
3
Practice Guidelines for Nutrition in Critically Ill Patients: A Relook for Indian Scenario.
危重症患者营养治疗实践指南:基于印度情况的重新审视
Indian J Crit Care Med. 2018 Apr;22(4):263-273. doi: 10.4103/ijccm.IJCCM_3_18.
4
The frequency, risk factors, and complications of gastrointestinal dysfunction during enteral nutrition in critically ill patients.危重症患者肠内营养期间胃肠道功能障碍的发生率、危险因素及并发症
Ther Clin Risk Manag. 2018 Feb 23;14:385-391. doi: 10.2147/TCRM.S158492. eCollection 2018.
5
The impact of early enteral nutrition on pediatric patients undergoing gastrointestinal anastomosis a propensity score matching analysis.早期肠内营养对接受胃肠道吻合术的儿科患者的影响:一项倾向评分匹配分析
Medicine (Baltimore). 2018 Mar;97(9):e0045. doi: 10.1097/MD.0000000000010045.
6
Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines.危重症患者的早期肠内营养:欧洲重症监护医学学会临床实践指南
Intensive Care Med. 2017 Mar;43(3):380-398. doi: 10.1007/s00134-016-4665-0. Epub 2017 Feb 6.
7
The management of perioperative nutrition in patients with end stage liver disease undergoing liver transplantation.终末期肝病患者肝移植围手术期的营养管理
Hepatobiliary Surg Nutr. 2015 Oct;4(5):336-44. doi: 10.3978/j.issn.2304-3881.2014.09.14.
8
[Enteral nutrition therapy in critical care : Current knowledge, controversies, and practical implementation].重症监护中的肠内营养治疗:当前知识、争议及实际应用
Med Klin Intensivmed Notfmed. 2016 May;111(4):330-40. doi: 10.1007/s00063-015-0048-5. Epub 2015 Jun 20.
9
Significant publications for pharmacy nutrition support practice in 2013.2013年药学营养支持实践的重要出版物。
Hosp Pharm. 2014 Sep;49(8):717-30. doi: 10.1310/hpj4908-717.